Freeme - ME/CFS and Long Covid

60
Freeme - ME/CFS and Long Covid
Freeme - ME/CFS and Long Covid is an iOS app from Freeme Health Ltd in the Education category, currently rated 4.7★ across 46 ratings. Initial signal reads as mixed reviews: supporters praise core features while critics cite stability and value gaps.
Quality Score is 60: Solid (established niche player). For a Education app, that means established niche player. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
📊 Performance Tracking LIVE
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| 📦 Asset bundle (69 MB) | +$7K |
| ⚙ Education complexity ×1.20 | +$11K |
Synthetic estimate. Multiple band derived from ad-supported + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.
| 📺 Ad-supported base | 15× MRR |
| ⭐ ★ rating ≥ 4.7 (premium) | +15% |
| 🏷 Education category multiple | +6% |
| ⭐ Small user base (<1K ratings) | -8% |
How we forecast this revenue
MEDIUM CONFIDENCEBU Investment Matrix
Pre-traction · 36/100INDIE TIERFREE (NO MONETIZATION)limited signal- 💰 Revenue: Modest — $1K - $7K/mo · INDIE tier · medium confidence, trajectory unclear.
- ⭐ Quality: 4.7★ across 46 reviews — weak — significant quality concerns.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Moderate — no material risk signals detected.
💰 Forecast Revenue / mo
MODEL| Paid app ($0.00)METRIC | +$2,800 | |
| Excellent rating (4.7★)METRIC | +$2,200 | |
| slowREVIEW | −$1,200 | |
| Single-language (English only)METRIC | −$400 | |
| Pre-traction phase (46 ratings)METRIC | −$300 | |
| Growing app (1y old)METRIC | +$200 |
📈 Reviews Growth
LIVE⭐ Rating Trend
LIVE🆕 What's New · v1.8.14 - 706
Profile & Insights
Identification
- App name
- Freeme - ME/CFS and Long Covid
- Developer
- Freeme Health Ltd
- Bundle ID
- com.mycompany.freeme
- App Store URL
- Open in App Store
- Category
- Education
- Content rating
- 17+
- Languages
- EN
Company
- Website
- Not found
- Tagline
- Take control of your ME/CFS or Long Covid
- Description
- Enter your email to get your download link. Take control of your ME, CFS or Long Covid in less than 15 minutes a day with the groundbreaking neuroscience based app.
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Available
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $3.2K/mo
- Top-grossing rank
- 🇦🇺#17 /100 🇬🇧#37 /100
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Funding
Press & Links
Contacts & Socials
- Socials
- facebook facebook.com/profile.php?id=615566594… · instagram instagram.com/the.freeme.app
- hello@freemehealth.com
- Phone
- Not found
- Contact page
- freemehealth.com/contact
- About page
- freemehealth.com/about
📈Ratings growth46 ratings+1433% lifetimeShow 3-year history estimate ▾
📝 About this app
TOOLS THAT ACTUALLY WORK
Freeme offers daily exercises and sessions that give you the knowledge and tools to actively reduce your symptoms.
THE NEUROSCIENCE APPROACH
Freeme is built on the latest neuroscience research. It focuses on the most crucial part of ME/CFS and Long Covid - a dysregulated nervous system.
FLARE-UP MODE… View full description on the official store →
What Worked™ · Development Pipeline
8 EVENTS TRACKEDVoice of Customer
Based on 71 reviews across 5 marketsMulti-Country Performance
Available in 9 of 9 monitored markets| Market | Rating | Reviews | Current version |
|---|---|---|---|
| 🇦🇺 AU | 4.625★ | 16 | 4.625★ this version |
| 🇧🇷 BR | 0★ | 0 | — |
| 🇨🇦 CA | 4.92307★ | 13 | 4.92307★ this version |
| 🇩🇪 DE | 4.92856★ | 14 | 4.92856★ this version |
| 🇫🇷 FR | 5★ | 1 | 5★ this version |
| 🇬🇧 GB | 4.77381★ | 84 | 4.77381★ this version |
| 🇮🇳 IN | 1★ | 1 | 1★ this version |
| 🇯🇵 JP | 0★ | 0 | — |
| 🇺🇸 US | 4.63999★ | 50 | 4.63999★ this version |
Track this app’s revenue
FREE📝 Description
95
Why low confidence: only 46 ratings · no founder-verified revenue (model estimate only) · revenue figure is directional only.



